79069-42-4

Basic information

• Product Name: Benzenamine, 2-bromo-4,6-bis(1-methylethyl)-
• Synonyms: 2-bromo-4,6-diisopropylaniline;2,6-diisopropyl-1-amino-2-bromo-benzene
• CAS NO: 79069-42-4
• Molecular Formula: C12H18BrN
• Molecular Weight: 256.186
• Mol File: 79069-42-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzenamine, 2-bromo-4,6-bis(1-methylethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, 2-bromo-4,6-bis(1-methylethyl)-(79069-42-4)
• EPA Substance Registry System: Benzenamine, 2-bromo-4,6-bis(1-methylethyl)-(79069-42-4)

Safety Data

• Hazardous Substances Data: 79069-42-4(Hazardous Substances Data)

Upstream product

• 79069-41-3 2,4-diisopropyl-aniline 
• 144-55-8 sodium hydrogencarbonate 

Relevant articles and documents

Fe(II) and Co(II) pyridinebisimine complexes bearing different substituents on ortho- and para-position of imines: Synthesis, characterization and behavior of ethylene polymerization

A series of 2,6-bis(imino)pyridyl iron(II) and cobalt(II) complexes [2,6-(ArNCMe)2C5H3N]MCl2 (Ar = 2,6-i-Pr2C6H3, M = Fe: 3a, M = Co: 4a; Ar = 2,4,6-i-Pr3C6H2, M = Fe: 3b, M = Co: 4b; Ar = 2,6-i-Pr2-4-BrC6H2, M = Fe: 3c, M = Co: 4c; Ar = 2,4-i-Pr2-6-BrC6H2, M = Fe: 3d, M = Co: 4d) has been synthesized, characterized, and investigated as precatalysts for the polymerization of ethylene in the presence of modified methylaluminoxane (MMAO). The substituents of pyridinebisimine ligands and their positions located significantly influence catalyst activity and polymer property. It is found that the catalytic activities of the iron complexes/MMAO systems are mainly dominated by electronical effect, while those of the cobalt complexes/MMAO systems are primarily controlled by hindering effect.

Trans-3-(4-oxo-4H-quinazolin-3-yl)-2-propenoic acid derivatives

Trans-3-(4-oxo-4H-quinazolin-3-yl)-2-propenoic acid derivatives of the formula STR1 wherein R1 is hydrogen, lower alkyl, lower cycloalkyl, lower alkoxy, hydroxy, halo, lower alkykthio, lower alkylsulfinyl, lower alkylsulfonyl, di-(C1 -C7)alkyl-N(CH2)n O-- or 2-hydroxyethoxy; R2 is hydrogen, lower alkyl or lower alkoxy; R3 is hydroxy, lower alkoxy, di-(C1 -C7)alkyl-N(CH2)n O-- or di-(C1 -C7)alkyl-N(CH2)n NH--; and n is 2 to 7; provided that at least one of R1 and R2 is other than hydrogen, when R3 is hydroxy, a salt thereof with a pharmaceutically acceptable base, or when R3 is di-(C1 -C7)alkyl-N(CH2)n O-- or di-(C1 -C7)alkyl-N(CH2)n NH--, a salt thereof with a pharmaceutically acceptable acid, and a process for the preparation thereof, are described. The compounds of formula I are useful as agents in the prevention of allergic reactions.